SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-101397
Filing Date
2020-09-01
Accepted
2020-09-01 16:15:52
Documents
2
Period of Report
2020-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030022d1_8k.htm 8-K 21954
2 EXHIBIT 10.1 tm2030022d1_ex10-1.htm EX-10.1 109691
  Complete submission text file 0001104659-20-101397.txt   133079
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36435 | Film No.: 201154618
SIC: 2836 Biological Products, (No Diagnostic Substances)